321 related articles for article (PubMed ID: 25786901)
1. Screening for malignancy in primary sclerosing cholangitis (PSC).
Khaderi SA; Sussman NL
Curr Gastroenterol Rep; 2015 Apr; 17(4):17. PubMed ID: 25786901
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk, screening and surveillance in primary sclerosing cholangitis.
Chascsa DM; Lindor KD
Minerva Gastroenterol Dietol; 2019 Sep; 65(3):214-228. PubMed ID: 31220911
[TBL] [Abstract][Full Text] [Related]
3. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
Bonato G; Cristoferi L; Strazzabosco M; Fabris L
Dig Dis; 2015; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
[TBL] [Abstract][Full Text] [Related]
4. An update on cancer risk and surveillance in primary sclerosing cholangitis.
Horsley-Silva JL; Rodriguez EA; Franco DL; Lindor KD
Liver Int; 2017 Aug; 37(8):1103-1109. PubMed ID: 28028930
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
Ehlken H; Schramm C
Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
Fung BM; Lindor KD; Tabibian JH
World J Gastroenterol; 2019 Feb; 25(6):659-671. PubMed ID: 30783370
[TBL] [Abstract][Full Text] [Related]
9. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
Bowlus CL; Lim JK; Lindor KD
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2416-2422. PubMed ID: 31306801
[TBL] [Abstract][Full Text] [Related]
10. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
11. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
12. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
[TBL] [Abstract][Full Text] [Related]
14. [Primary sclerosing cholangitis].
Boonstra K; Ponsioen CI; Rauws EA; Beuers U
Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
Bergquist A; Glaumann H; Persson B; Broomé U
Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis and malignancy.
Boberg KM; Lind GE
Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):753-64. PubMed ID: 22117640
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
Eaton JE; Talwalkar JA; Lazaridis KN; Gores GJ; Lindor KD
Gastroenterology; 2013 Sep; 145(3):521-36. PubMed ID: 23827861
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
Bergquist A; Broomé U
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
